Prevalence and Predictors of Glucose Metabolism Disorders Among HIV Patients Attending the HIV Clinic at Bugando Medical Centre (Record no. 18380)

MARC details
000 -LEADER
fixed length control field 04011nam a22001817a 4500
008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION
fixed length control field 210820b |||||||| |||| 00| 0 eng d
100 ## - MAIN ENTRY--PERSONAL NAME
Personal name Maganga, Emmanuel. Paschal.
9 (RLIN) 22654
245 ## - TITLE STATEMENT
Title Prevalence and Predictors of Glucose Metabolism Disorders Among HIV Patients Attending the HIV Clinic at Bugando Medical Centre
260 ## - PUBLICATION, DISTRIBUTION, ETC.
Place of publication, distribution, etc. Mwanza, Tanzania:
Name of publisher, distributor, etc. Catholic University of Health and Allied Sciences CUHAS - Bugando
Date of publication, distribution, etc. c2013
300 ## - PHYSICAL DESCRIPTION
Extent xii; 64 Pages
Extent Includes References and Appendices
520 ## - SUMMARY, ETC.
Summary, etc. Abstract:<br/><br/>Background: Mortality and morbidity from human immunodeficiency Virus (HIV) infection and its complications have dramatically declined since the advent of combination antiretroviral therapies (ARTs). This has transformed the disease from an inexorably fatal illness to a chronic condition where infected individuals with access to the drugs can live a long healthy life. However, metabolic disorders such as diabetes mellitus (DM), lipid disorders and cardiovascular diseases have emerged as a growing concern in this population. With the increase in availability and accessibility of ARTs worldwide there has been an increasing prevalence of long-term side effects including HIV lipodystrophy, carbohydrate metabolism and lipid metabolism abnormalities among a patients. Several risk factors have been linked including increased age, sex, change in body mass index (BMI), low CD4 count, as well as the type and duration of ART the HIV patient is using, especially protease inhibitors (PIs) and nucleoside reverse transcriptase inhibitors (NRTIs). Little is known about the magnitude and predictors glucose metabolism disorders in Tanzania despite the reported increase in frequency in the west as well as in Africa.<br/><br/>Methodology: This was an analytical cross-sectional study, which was conducted at the Bugando Medical Centre (BMC) Care and Treatment Centre (CTC) among 461 participant: 153 HIV positive ART naïve patients, 153 HIV patients on ART for more than 2 years and 155 HIV negative controls. An oral glucose tolerance test (OGTT) and fasting blood glucose (FBG) were performed in each patient and compared with standard World Health Organization (WHO) clinical definition for impaired fasting blood glucose (IFBG) and DM.<br/><br/>Results: A total of 461 participants were serially enrolled into the study in the three groups as described above. In the HIV positive group on ART for >2 years the median age was 40 years [38-47] and 118 (77.1%) were female, in the HIV negative group, the median age was 37 years [32-44] and 91 (95%) were female; and in HIV positive ART naïve group the median age was 40 years [38-47] and 118 (77.1%) were female. Among patients on ART, 49(32%) had one or more forms of glucose metabolism disorders compared to 7.1% (11 participants), and 8.5% (13 participants) among HIV negative and ART naïve groups respectively. The prevalence of overt DM was also high among patient on ART 27 (17.7%) as compared to 5.2% (8 participants) and 0.7% ( 1 participants) among HIV-negative and ART naïve groups respectively. These were when both FBG and OGTT were done. Most of patients with GMD were captured by FBG test than OGTT. HIV status and central obesity were significantly associated with glucose metabolism disorders (2.44 [1.48 – 4.0], p<0.001) and (2.8 [1.22-6.79], p=0.016 respectively. Protease inhibitor use showed a trend toward being a positive predictor of the glucose metabolism disorders but was not statistically significant (2.21 [0.66-7.35]). <br/><br/>Conclusions: Participants who were on ART had high prevalence of glucose metabolic disorders compared to their counterparts (HIV-negatives and HIV positive ART naïve). The strongest predictor of DM in this population was abdominal obesity. The prevention of abdominal obesity would likely help to prevent GMDs.<br/>
600 ## - SUBJECT ADDED ENTRY--PERSONAL NAME
General subdivision Internal Medicine
9 (RLIN) 15587
700 ## - ADDED ENTRY--PERSONAL NAME
9 (RLIN) 22760
9 (RLIN) 48386
9 (RLIN) 22817
942 ## - ADDED ENTRY ELEMENTS (KOHA)
Source of classification or shelving scheme ddc
Koha item type POSTGRADUATE DISSERTATIONS
Holdings
Withdrawn status Lost status Source of classification or shelving scheme Damaged status Not for loan Collection Home library Current library Shelving location Date acquired Total checkouts Barcode Date last seen Price effective from Koha item type
            MWALIMU NYERERE LEARNING RESOURCES CENTRE-CUHAS BUGANDO MWALIMU NYERERE LEARNING RESOURCES CENTRE-CUHAS BUGANDO   08/20/2021   PD0234 08/20/2021 08/20/2021 POSTGRADUATE DISSERTATIONS
Catholic University of  Health and Allied Sciences - CUHAS
Directorate of ICT @ 2024